A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept—drugs widely used to treat certain autoimmune ...
Jun 3, 2022
0
51
Blocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms by reducing inflammation, tissue injury and blood clots in the lungs, new research in mice suggests.
Jun 1, 2022
0
99
University at Buffalo biomedical informatics researchers have found that patients hospitalized with COVID-19 pneumonia had a 13.5% survival advantage when treated with a combination of leukotriene inhibitors (LTIs) and the ...
May 25, 2022
0
64
Researchers from Queen Mary University of London have combined evidence from 110 previous COVID-19 studies and found that unvaccinated individuals who contract the virus when they already have high blood pressure, diabetes ...
May 4, 2022
0
28
In the majority of cases, children who catch COVID won't end up suffering serious illness. Kids have fewer symptoms, less severe disease, and tend to recover faster than adults.
May 3, 2022
0
7
Researchers have discovered the blood clotting and immune protein pathways that are activated in severe cases of COVID-19 in children, paving the way for earlier diagnosis and more targeted treatments.
May 2, 2022
0
134
Inhaled nitric oxide (iNO) is associated with improvement in the mean partial pressure of oxygen (PaO2)/fraction of inspired oxygen (FiO2) ratio (P/F ratio) among patients hospitalized with COVID-19 and mild-to-moderate acute ...
Apr 22, 2022
0
7
Inspired by the advanced analytics used in sports, a Northwestern University-led research team has developed a new approach for measuring physician adherence to best practices. The study also shows that high-performing individuals ...
Apr 5, 2022
0
5
Scientists have discovered a new family of helpful proteins in the lung, with the finding potentially paving the way for a new course of treatment for patients with respiratory failure.
Mar 23, 2022
0
32
A team of researchers from Harvard Medical School and Boston Children's Hospital has developed a device to help patients experiencing refractory hypoxemia. In their paper published in Proceedings of the National Academy of ...
